260 related articles for article (PubMed ID: 9833612)
1. Molecular heterogeneity of hCGbeta--related glycoproteins and the clinical relevance in trophoblastic and non-trophoblastic tumors.
Nishimura R; Koizumi T; Yokotani T; Taniguchi R; Morisue K; Yoshimura M; Hiranmoy D; Yamaguchi S; Nakagawa T; Hasegawa K; Yasui H
Int J Gynaecol Obstet; 1998 Apr; 60 Suppl 1():S29-32. PubMed ID: 9833612
[TBL] [Abstract][Full Text] [Related]
2. Molecular heterogeneity of hCG β - related glycoproteins and the clinical relevance in trophoblastic and non-trophoblastic tumors.
Nishimura R; Koizumi T; Yokotani T; Taniguchi R; Morisue K; Yoshimura M; Hiranmoy D; Yamaguchi S; Nakagawa T; Hasegawa K; Yasui H
Int J Gynaecol Obstet; 1998 Apr; 60 Suppl 1():S29-S32. PubMed ID: 29645231
[TBL] [Abstract][Full Text] [Related]
3. Human chorionic gonadotropin (hCG) beta-core fragment is produced by degradation of hCG or free hCG beta in gestational trophoblastic tumors: a possible marker for early detection of persistent postmolar gestational trophoblastic disease.
Okamoto T; Matsuo K; Niu R; Osawa M; Suzuki H
J Endocrinol; 2001 Dec; 171(3):435-43. PubMed ID: 11739009
[TBL] [Abstract][Full Text] [Related]
4. [Molecular heterogeneity of hCG in urine of the patients with trophoblastic diseases].
Kitajima T; Mochizuki M; Nishimura R
Nihon Sanka Fujinka Gakkai Zasshi; 1991 Mar; 43(3):297-303. PubMed ID: 1710641
[TBL] [Abstract][Full Text] [Related]
5. Combination assay of urinary beta-core fragment of human chorionic gonadotropin with serum tumor markers in gynecologic cancers.
Kinugasa M; Nishimura R; Koizumi T; Morisue K; Higashida T; Natazuka T; Nakagawa T; Isobe T; Baba S; Hasegawa K
Jpn J Cancer Res; 1995 Aug; 86(8):783-9. PubMed ID: 7559103
[TBL] [Abstract][Full Text] [Related]
6. Enzyme Immunoassay of Urinary β-Core Fragment of Human Chorionic Gonadotropin as a Tumor Marker for Ovarian Cancer.
Nishimura R; Koizumi T; Das H; Takemori M; Hasegawa K
Methods Mol Med; 2001; 39():135-41. PubMed ID: 21340764
[TBL] [Abstract][Full Text] [Related]
7. Assessment of urinary beta-core fragment of human chorionic gonadotropin as a new tumor marker of lung cancer.
Yoshimura M; Nishimura R; Murotani A; Miyamoto Y; Nakagawa T; Hasegawa K; Koizumi T; Shii K; Baba S; Tsubota N
Cancer; 1994 Jun; 73(11):2745-52. PubMed ID: 7514953
[TBL] [Abstract][Full Text] [Related]
8. Radioimmunoassay of the serum free beta-subunit of human chorionic gonadotropin in trophoblastic disease.
Fan C; Goto S; Furuhashi Y; Tomoda Y
J Clin Endocrinol Metab; 1987 Feb; 64(2):313-8. PubMed ID: 2432080
[TBL] [Abstract][Full Text] [Related]
9. [Ectopic production of HCG beta by bladder carcinoma in vitro and in vivo].
Morisue K; Yamanaka N; Eto H; Kamidono S; Nishimura R
Nihon Hinyokika Gakkai Zasshi; 1996 Mar; 87(3):643-9. PubMed ID: 8709440
[TBL] [Abstract][Full Text] [Related]
10. The molar vesicle fluid contains the beta-core fragment of human chorionic gonadotropin.
Khan S; Katabuchi H; Araki M; Ohba T; Koizumi T; Okamura H; Nishimura R
Placenta; 2000 Jan; 21(1):79-87. PubMed ID: 10692255
[TBL] [Abstract][Full Text] [Related]
11. Clinical utility of hyperglycosylated hCG in serum taken before hydatidiform mole evacuation to predict persistent trophoblastic disease.
Duc HN; van Trommel NE; Sweep FC; Massuger LF; Thomas CM
Int J Biol Markers; 2006; 21(1):45-9. PubMed ID: 16711513
[TBL] [Abstract][Full Text] [Related]
12. Human chorionic gonadotropin beta-core fragment is directly produced by cancer cells.
Okamoto T; Niu R; Matsuo K; Furuhashi M; Ohsawa M; Mizutani S; Suzuki H
Life Sci; 2001 Jan; 68(8):861-72. PubMed ID: 11213356
[TBL] [Abstract][Full Text] [Related]
13. Evidence for altered synthesis of human chorionic gonadotropin in gestational trophoblastic tumors.
Vaitukaitis JL; Ebersole ER
J Clin Endocrinol Metab; 1976 Jun; 42(6):1048-55. PubMed ID: 180043
[TBL] [Abstract][Full Text] [Related]
14. Expression and secretion of the beta subunit of human chorionic gonadotropin by bladder carcinoma in vivo and in vitro.
Nishimura R; Koizumi T; Morisue K; Yamanaka N; Lalwani R; Yoshimura M; Nakagawa T; Shii K; Hasegawa K; Baba S
Cancer Res; 1995 Apr; 55(7):1479-84. PubMed ID: 7882356
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis of hydatidiform mole and persistent trophoblastic disease: diagnostic accuracy of total human chorionic gonadotropin (hCG), free hCG {alpha}- and {beta}-subunits, and their ratios.
van Trommel NE; Sweep FC; Schijf CP; Massuger LF; Thomas CM
Eur J Endocrinol; 2005 Oct; 153(4):565-75. PubMed ID: 16189178
[TBL] [Abstract][Full Text] [Related]
16. Selective expression of trophoblastic hormones by lung carcinoma: neurendocrine tumors exclusively produce human chorionic gonadotropin alpha-subunit (hCGalpha).
Dirnhofer S; Freund M; Rogatsch H; Krabichler S; Berger P
Hum Pathol; 2000 Aug; 31(8):966-72. PubMed ID: 10987258
[TBL] [Abstract][Full Text] [Related]
17. Gestational trophoblastic diseases: 3. Human chorionic gonadotropin-free beta-subunit, a reliable marker of placental site trophoblastic tumors.
Cole LA; Khanlian SA; Muller CY; Giddings A; Kohorn E; Berkowitz R
Gynecol Oncol; 2006 Aug; 102(2):160-4. PubMed ID: 16631918
[TBL] [Abstract][Full Text] [Related]
18. [Clinical significance of pregnancy-specific beta glycoprotein, human placental lactogen and beta-human chorionic gonadotropin in the serum of patients with trophoblastic diseases].
Zhang WY
Zhonghua Yi Xue Za Zhi; 1989 Apr; 69(4):206-8, 16. PubMed ID: 2476204
[TBL] [Abstract][Full Text] [Related]
19. Detection of hCG in trophoblastic disease. The USA hCG reference service experience.
Cole LA; Butler S
J Reprod Med; 2002 Jun; 47(6):433-44. PubMed ID: 12092011
[TBL] [Abstract][Full Text] [Related]
20. Elevated hCG and a high proportion of hCGbeta in serum preceding the diagnosis of trophoblastic disease by seven months.
Vartiainen J; Alfthan H; Lehtovirta P; Stenman UH
BJOG; 2002 May; 109(5):589-90. PubMed ID: 12066956
[No Abstract] [Full Text] [Related]
[Next] [New Search]
